Diagnosis and classification of intestinal diseases with urine by surface-enhanced Raman spectroscopy

被引:0
作者
Li, Silong [1 ]
Zheng, Yuqing [1 ]
Yang, Yiheng [2 ]
Yang, Haojie [2 ]
Han, Changpeng [2 ]
Du, Peng [3 ]
Wang, Xiaolei [4 ]
Yang, Huinan [1 ]
机构
[1] Univ Shanghai Sci & Technol, Sch Energy & Power Engn, Shanghai 200093, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western M, Shanghai 200437, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200092, Peoples R China
[4] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200072, Peoples R China
基金
中国国家自然科学基金;
关键词
Surface -enhanced Raman spectroscopy; Urine; Intestinal disease; PCA-SVM;
D O I
10.1016/j.saa.2024.124081
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Intestinal Disease (ID) is often characterized by clinical symptoms such as malabsorption, intestinal dysfunction, and injury. If treatment is not timely, it will increase the risk of cancer. Early diagnosis of ID is the key to cure it. There are certain limitations of the conventional diagnostic methods, such as low sensitivity and specificity. Therefore, development of a highly sensitive, non-invasive diagnostic method for ID is extremely important. Urine samples are easier to collect and more sensitive to changes in biomolecules than other pathological diagnostic samples such as tissue and blood. In this paper, a diagnostic method of ID with urine by surfaceenhanced Raman spectroscopy (SERS) is proposed. A classification model between ID patients and healthy controls (HC) and a classification model between different pathological types of ID (i.e., benign intestinal disease (BID) and colorectal cancer (CRC)) are established. Here, 830 urine samples, including 100 HC, 443 BID, and 287 CRC, were investigated by SERS. The ID/HC classification model was developed by analyzing the SERS spectra of 150 ID and 100 HC, while BID/CRC classification model was built with 300 BID and 150 CRC patients by principal component analysis (PCA)-support vector machines (SVM). The two established models were internally verified by leave -one -out -cross -validation (LOOCV). Finally, the BID/CRC classification model was further evaluated by 143 BID and 137 CRC patients as an external test set. It shows that the accuracy of the classification model validated by the LOOCV for ID/HC and BID/CRC is 86.4% and 85.56%, respectively. And the accuracy of the BID/CRC classification model with external test set is 82.14%. It shows that high accuracy can be achieved with these two established classification models. It indicates that ID patients in the general population can be identified and BID and CRC patients can be further classified with measuring urine by SERS. It shows that the proposed diagnostic method and established classification models provide valuable information for clinicians to early diagnose ID patients and analyze different stages of ID.
引用
收藏
页数:9
相关论文
共 38 条
  • [1] Gold nanoparticles-based assays for biodetection in urine
    Antonio, Maria
    Vitorino, Rui
    Daniel-da-Silva, Ana L.
    [J]. TALANTA, 2021, 230
  • [2] Urine Drug Testing in Cancer Pain Management
    Arthur, Joseph A.
    [J]. ONCOLOGIST, 2020, 25 (02) : 99 - 104
  • [3] SinoCaps: Recognition of colorectal polyps using sinogram capsule network
    Ayidzoe, Mighty Abra
    Yu, Yongbin
    Mensah, Patrick Kwabena
    Cai, Jingye
    Baagyere, Edward Yellakuor
    Bawah, Faiza Umar
    [J]. JOURNAL OF INTELLIGENT & FUZZY SYSTEMS, 2023, 44 (02) : 3079 - 3091
  • [4] Complications of Colonoscopy
    Church, James
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2013, 42 (03) : 639 - +
  • [5] Surface Enhanced Raman Scattering Revealed by Interfacial Charge-Transfer Transitions
    Cong, Shan
    Liu, Xiaohong
    Jiang, Yuxiao
    Zhang, Wei
    Zhao, Zhigang
    [J]. INNOVATION, 2020, 1 (03):
  • [6] Differential of cholangiocarcinoma disease using Raman spectroscopy combined with multivariate analysis
    Depciuch, Joanna
    Parlinska-Wojtan, Magdalena
    Serin, Kursat Rahmi
    Bulut, Huri
    Ulukaya, Engin
    Tarhan, Nevzat
    Guleken, Zozan
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2022, 272
  • [7] Approaches to urinary detection of prostate cancer
    Eskra, Jillian N.
    Rabizadeh, Daniel
    Pavlovich, Christian P.
    Catalona, William J.
    Luo, Jun
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (03) : 362 - 381
  • [8] BidSi6 and BidEL isoforms as a potential marker for predicting colorectal adenomatous polyps
    Forouzesh, Flora
    Kia, Fatemeh Sadat
    Nazemalhosseini-Mojarad, Ehsan
    [J]. BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [9] Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by 1H-NMR Spectrometry
    Gu, Jinping
    Xiao, Yaqing
    Shu, Dan
    Liang, Xianrui
    Hu, Xiaomin
    Xie, Yuanyuan
    Lin, Donghai
    Li, Hua
    [J]. DISEASE MARKERS, 2019, 2019
  • [10] SERS platform for detection of lipids and disease markers prepared using modification of plasmonic-active gold gratings by lipophilic moieties
    Guselnikova, Olga
    Kalachyova, Yevgeniya
    Hrobonova, Karolina
    Trusova, Marina
    Barek, Jiri
    Postnikov, Pavel
    Svorcik, Vaclav
    Lyutakov, Oleksiy
    [J]. SENSORS AND ACTUATORS B-CHEMICAL, 2018, 265 : 182 - 192